Search research articles
Contact Us
Filters
Showing results (231-240 of 292) with videos related to
Page
of 30
Sort By:
Focus (American Psychiatric Publishing)
|
September 6, 2021
The Impact of Pharmacological and Non-Pharmacological Interventions to Improve Physical Health Outcomes in People With Schizophrenia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials
Davy Vancampfort, Joseph Firth, Christoph U Correll, et al.
Epidemiology and Psychiatric Sciences
|
November 17, 2022
Colorectal cancer treatment in people with severe mental illness: a systematic review and meta-analysis
Melinda M Protani, Meshary Khaled N Alotiby, Rebecca Seth, et al.
Bjpsych Open
|
April 27, 2026
SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disorders
Urska Arnautovska, Gabrielle Ritchie, Nicole Korman, et al.
CNS Drugs
|
September 11, 2025
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial
Matin Mortazavi, Zahra Aminifarsani, Inge Winter-van Rossum, et al.
CNS Spectrums
|
December 20, 2024
Clozapine rechallenge following myocarditis: a systematic review of rechallenge cases
Laura McMahon, Maddison Giudice, Elias Wagner, et al.
Schizophrenia Bulletin
|
March 21, 2023
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
Elias Wagner, Dan Siskind, Peter Falkai, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 15, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis - ADDENDUM
Elias Wagner, Nicole Korman, Marco Solmi, et al.
The Australian and New Zealand Journal of Psychiatry
|
January 16, 2026
<i>Australian and New Zealand Journal of Psychiatry</i> Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia
Shuichi Suetani, Frances Dark, Susanna Every-Palmer, et al.
The Lancet. Psychiatry
|
June 12, 2025
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia
Dan Siskind, Andrea Baker, Urska Arnautovska, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 2, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis
Elias Wagner, Nicole Korman, Marco Solmi, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 292) with videos related to
Sort By:
Page
of 30
Focus (American Psychiatric Publishing)
|
September 6, 2021
The Impact of Pharmacological and Non-Pharmacological Interventions to Improve Physical Health Outcomes in People With Schizophrenia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials
Davy Vancampfort, Joseph Firth, Christoph U Correll, et al.
Epidemiology and Psychiatric Sciences
|
November 17, 2022
Colorectal cancer treatment in people with severe mental illness: a systematic review and meta-analysis
Melinda M Protani, Meshary Khaled N Alotiby, Rebecca Seth, et al.
Bjpsych Open
|
April 27, 2026
SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disorders
Urska Arnautovska, Gabrielle Ritchie, Nicole Korman, et al.
CNS Drugs
|
September 11, 2025
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial
Matin Mortazavi, Zahra Aminifarsani, Inge Winter-van Rossum, et al.
CNS Spectrums
|
December 20, 2024
Clozapine rechallenge following myocarditis: a systematic review of rechallenge cases
Laura McMahon, Maddison Giudice, Elias Wagner, et al.
Schizophrenia Bulletin
|
March 21, 2023
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
Elias Wagner, Dan Siskind, Peter Falkai, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 15, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis - ADDENDUM
Elias Wagner, Nicole Korman, Marco Solmi, et al.
The Australian and New Zealand Journal of Psychiatry
|
January 16, 2026
<i>Australian and New Zealand Journal of Psychiatry</i> Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia
Shuichi Suetani, Frances Dark, Susanna Every-Palmer, et al.
The Lancet. Psychiatry
|
June 12, 2025
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia
Dan Siskind, Andrea Baker, Urska Arnautovska, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 2, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis
Elias Wagner, Nicole Korman, Marco Solmi, et al.
Page
of 30